Insulin therapy in type 2 diabetic subjects suppresses plasminogen activator inhibitor (PAI-1) activity and proinsulin-like molecules independently of glycemic control. - Jain,S.K.; Nagi,D.K.; Slavin,B.M.; Lumb,P.J.; Yudkin,J.S. (Diabetic Med, 1993)